West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012

Emerging Infectious Diseases

Volumn 21, Issue 4, 2015, Pages 681-683

  Cervantes, Diana T ^a   Chen, Shande ^b   Sutor, Laurie J ^c   Stonecipher, Shelley ^a   Janoski, Nicolette ^d   Wright, David J ^e   Busch, Michael P ^f  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c Carter BloodCare   (United States)

^d Tarrant County Public Health Department   (United States)

^e WESTAT   (United States)

^f Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EXTERNAL VALIDITY; FEMALE; HUMAN; INCIDENCE; INFECTION RATE; INTERNAL VALIDITY; MALE; MIDDLE AGED; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PUBLIC HEALTH; RISK; UNITED STATES; WEST NILE FEVER; CHILD; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; SEASON; VERY ELDERLY; VIREMIA; VIROLOGY; WEST NILE VIRUS; YOUNG ADULT;

VIRUS RNA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RNA, VIRAL; SEASONS; SEROEPIDEMIOLOGIC STUDIES; TEXAS; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 84924955394     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2104.141178     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention, ArboNET. West Nile virus disease cases reported to CDC by state, 1999-2013 [cited 2015 Feb 13]. http://www.cdc.gov/westnile/resources/pdfs/cummulative/99_2013_cummulativeHumanCases.pdf
2. Petersen LR, Busch MP. Transfusion-transmitted arboviruses. Vox Sang. 2010;98:495-503 http://dx.doi.org/10.1111/j.1423-0410.2009.01286.x.
3. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004;44:1547-54. http://dx.doi.org/10.1111/j.0041-1132.2004.04227.x
4. Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, et al. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Transfusion. 2009;49:1160-70. http://dx.doi.org/10.1111/j.1537-2995.2009.02127.x
5. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, and Glynn SA. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis.2006; 12(3): 395-402.
6. Carson PJ, Borchardt SM, Custer B, Prince HE, Dunn-Williams J, Winkelman V, et al. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis. 2012;18:684-6. http://dx.doi.org/10.3201/eid1804.111313
7. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, et al. Virus and Antibody Dynamics in Acute West Nile Virus Infection. J Infect Dis. 2008;198:984-93. http://dx.doi. org/10.1086/591467
8. Texas Department of State Health Services, Center for Health Statistics. Texas health data—population. [cited 2014 May 26]. http://soupfin.tdh.state.tx.us/people.htm
9. Miller RG. Survival analysis. New York: John Wiley; 1981.
10. Shaz BH, James AB, Hillyer KL, Schreiber GB, Hillyer CD. Demographic variations in blood donor deferrals in a major metropolitan area. Transfusion. 2010;50:881-7. http://dx.doi.org/10.1111/j.1537-2995.2009.02501.x
11. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310:308-15. http://dx.doi.org/10.1001/jama.2013.8042
12. Schweitzer BK, Kramer WL, Sambol AR, Meza JL, Hinrichs SH, Iwen PC. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314-8. http://dx.doi.org/10.1128/CVI.13.3.314-318.2006